# GO	NS	enrichment	name	ratio_in_study	ratio_in_pop	p_uncorrected	depth	study_count	p_fdr_bh	study_items
GO:0006397	BP	e	mRNA processing	9/9	228/6920	3.919926128544498e-14	8	9	1.797678122550507e-10	CFT1, CFT2, FIP1, MPE1, PAP1, PFS2, PTA1, YSH1, YTH1
GO:0016071	BP	e	mRNA metabolic process	9/9	340/6920	1.5074520121790718e-12	7	9	3.4565874639266117e-09	CFT1, CFT2, FIP1, MPE1, PAP1, PFS2, PTA1, YSH1, YTH1
GO:0006396	BP	e	RNA processing	9/9	687/6920	8.934367535480665e-10	4	9	1.3657669839238109e-06	CFT1, CFT2, FIP1, MPE1, PAP1, PFS2, PTA1, YSH1, YTH1
GO:0006369	BP	e	termination of RNA polymerase II transcription	4/9	25/6920	1.6494650023922656e-08	9	4	1.8911116252427324e-05	CFT1, MPE1, PTA1, YSH1
GO:0016070	BP	e	RNA metabolic process	9/9	1035/6920	3.6359771171368615e-08	6	9	3.33491821183793e-05	CFT1, CFT2, FIP1, MPE1, PAP1, PFS2, PTA1, YSH1, YTH1
GO:0006353	BP	e	DNA-templated transcription termination	4/9	41/6920	1.3082846401676538e-07	8	4	9.999655599681434e-05	CFT1, MPE1, PTA1, YSH1
GO:0090304	BP	e	nucleic acid metabolic process	9/9	1452/6920	7.730654315278111e-07	5	9	0.000506468295569506	CFT1, CFT2, FIP1, MPE1, PAP1, PFS2, PTA1, YSH1, YTH1
GO:0006139	BP	e	nucleobase-containing compound metabolic process	9/9	1687/6920	2.992663280631791e-06	4	9	0.001715544225622174	CFT1, CFT2, FIP1, MPE1, PAP1, PFS2, PTA1, YSH1, YTH1
GO:0031123	BP	e	RNA 3'-end processing	3/9	65/6920	6.382950133775156e-05	5	3	0.03252467701499207	PAP1, PFS2, YSH1
